Chronic Mesenteric Ischemia, MALS, and Mesenteric Arterial Dissection
Chronic mesenteric ischemia diagnosed only when symptom pattern and arterial anatomy explain each other: postprandial pain, weight loss, food fear, and significant mesenteric arterial obstruction. The chapter frames diagnosis, the open versus endovascular revascularization decision, median arcuate ligament syndrome, and mesenteric arterial dissection.
Consult corner: A bedside consult-style discussion focused on what the clinician should decide next and what not to overinterpret.
General medical education, not patient-specific advice.
Choose the hostsDefinition and clinical presentation
Chronic mesenteric ischemia (CMI) is a clinicoradiologic diagnosis defined by symptomatic intestinal hypoperfusion and significant mesenteric arterial obstruction. Because the celiac artery, superior mesenteric artery (SMA), and inferior mesenteric artery (IMA) share robust collateral networks, symptomatic CMI typically reflects multivessel atherosclerotic disease .
The classic presentation features:
- Postprandial abdominal pain, typically predictable in onset after eating.
- Food fear and reduced meal size.
- Unexplained weight loss.
Symptoms are suggestive rather than specific, frequently prompting extensive evaluation for functional or structural gastrointestinal disease before a vascular diagnosis is established . Acute-on-chronic mesenteric ischemia presents with a sudden escalation in symptom severity or a new pain pattern. This presentation shifts the pathology from an elective revascularization problem to a bowel-viability emergency, requiring urgent imaging and operative evaluation .
Diagnosis and anatomic evaluation
A definitive diagnosis requires symptom-anatomy correlation and exclusion of competing gastrointestinal pathology. Multidisciplinary evaluation incorporating vascular surgery, interventional radiology, gastroenterology, and dietetics optimizes case selection and nutritional assessment .
Computed tomography angiography (CTA) provides essential anatomic mapping, defining ostial origins, lesion length, calcification, distal target vessels, and collateral pathways. Mesenteric duplex ultrasound confirms hemodynamic significance. A peak systolic velocity greater than 275 cm/s in the SMA supports an anatomic stenosis greater than 70%, establishing the functional severity of the lesion . The companion celiac-axis cutoff is a peak systolic velocity of 200 cm/s or greater, or an end-diastolic velocity above 55 cm/s, indicating celiac stenosis of 70% or greater; both vessels are interrogated because CMI is multivessel disease and the celiac artery is one of the two diagnostically pivotal targets. Frailty scoring and dietetic assessment are performed at diagnosis, as profound malnutrition embedded in the disease increases the hazard of intervention .
Treatment thresholds and revascularization
Intervention is indicated for symptomatic CMI confirmed by significant anatomic and hemodynamic obstruction. The SMA is the primary revascularization target: it supplies the postprandial intestinal bed most directly, and restoring SMA inflow most often determines durable symptom relief . Incidental asymptomatic stenosis is managed conservatively, with individualized exceptions for patients planned for major abdominal surgery that may disrupt established collateral pathways. Systemic atherosclerosis medical therapy, including statin administration, antiplatelet therapy, blood-pressure control, and smoking cessation, is initiated at diagnosis .
Asymptomatic
- Lesion or finding
- Incidental stenosis on imaging
- Preferred action
- Continued observation unless major abdominal surgery is planned
CitationElderly, frail, or high comorbidity
- Lesion or finding
- Symptomatic CMI suitable for stenting
- Preferred action
- Endovascular revascularization
CitationFit, young, or recurrent
- Lesion or finding
- Long-segment occlusion or hostile ostial calcification
- Preferred action
- Open mesenteric bypass
CitationAcute-on-chronic
- Lesion or finding
- Sudden pain escalation or severe disproportionate pain
- Preferred action
- Urgent CTA and emergency intervention
Citation
The treatment decision follows an ordered algorithm:
- Competing gastrointestinal diagnoses are excluded and symptom-anatomy correlation is confirmed.
- Optimal medical therapy and nutritional repletion are initiated.
- Endovascular revascularization is selected as the default for elderly, malnourished, or high-risk patients to minimize early procedural morbidity, accepting a higher risk of restenosis and reintervention.
- Open mesenteric bypass (offering 5-year primary patency of 80 to 90%) is selected for fit, younger patients, or those with long-segment occlusions, recurrent disease, or calcification unsuitable for stenting, prioritizing long-term durability over initial operative morbidity.
Median arcuate ligament syndrome
Median arcuate ligament syndrome (MALS) is a distinct entity characterized by postprandial pain, weight loss, nausea, and dynamic celiac-axis compression by the median arcuate ligament. It is most frequently diagnosed in young women. Precision anatomic evaluation requires CTA with dynamic phases, duplex assessment with respiratory variation, and celiac plexus assessment .
Surgical release of the median arcuate ligament is indicated for highly selected patients meeting specific diagnostic criteria with negative functional and structural gastrointestinal evaluations. Minimally invasive and robotic platforms achieve effective symptom relief and shorter hospital stays compared to open release . Objective mesenteric ischemia is uncommon in this population, and surgical success is measured by symptom resolution rather than physiological flow restoration .
Isolated visceral artery dissection
Spontaneous isolated dissection of the SMA or celiac artery presents with acute or chronic abdominal pain mimicking occlusive ischemia. CTA distinguishes the dissection morphology from atherosclerosis. Initial management of uncomplicated isolated dissection is conservative, using antithrombotic therapy (antiplatelet or anticoagulation) and serial imaging surveillance .
Endovascular therapy is reserved for patients with persistent malperfusion, progressive symptoms, or an expanding false lumen. Open surgical reconstruction is a bailout option when endovascular techniques fail. Most conservatively managed patients demonstrate radiologic stability or resolution on follow-up imaging .
Surveillance and follow-up
Post-revascularization surveillance tracks symptoms, weight, dietary tolerance, and structural patency. Following endovascular CMI therapy, mesenteric duplex is scheduled at 1, 3, 6, and 12 months, and annually thereafter . Early detection of in-stent restenosis facilitates preemptive reintervention before symptomatic relapse and recurrent malnutrition occur.
Symptom recurrence requires careful interpretation. Renewed food fear, weight loss, and postprandial pain warrant prompt CTA and duplex imaging. Conversely, vague dyspepsia without weight loss requires gastrointestinal evaluation before presuming technical failure . Follow-up of conservatively managed visceral artery dissection relies on scheduled imaging to monitor for pseudoaneurysm formation or aneurysmal degeneration of the false lumen .
Areas of controversy
The causative mechanism of median arcuate ligament syndrome remains debated, with persistent uncertainty regarding the relative contributions of ischemic flow reduction versus celiac plexus neurogenic pain . Comparative outcomes between open and endovascular CMI revascularization are confounded by significant selection bias, complicating robust cost-effectiveness analyses . Duplex velocity thresholds for in-stent restenosis are center-specific and lack uniformly established criteria . The optimal agent and duration for antithrombotic therapy in isolated visceral artery dissection remain heterogeneous across protocols . The clinical implications and timing of recovery for CMI-associated intestinal dysbiosis following revascularization remain uncertain .
References
- 1.
- 2.European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Ga. 2020.PubMed-indexed articleClinical practice guideline2020
European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Ga. 2020. doi:10.1177/2050640620916681.
- 3.Acute and chronic mesenteric ischemia: single center analysis of open, endovascular, and hybrid surgery. BMC surgery. 2022.PubMed-indexed articleRegistry / cohort2022
Acute and chronic mesenteric ischemia: single center analysis of open, endovascular, and hybrid surgery. BMC surgery. 2022. doi:10.1186/s12893-022-01511-4.
- 4.Hospital frailty risk score and outcomes of chronic mesenteric ischemia revascularization: Nationwide Inpatient Sample 2005-2020 analysis. Medicine. 2024.PubMed-indexed articleRegistry / cohort2024
Hospital frailty risk score and outcomes of chronic mesenteric ischemia revascularization: Nationwide Inpatient Sample 2005-2020 analysis. Medicine. 2024. doi:10.1097/md.0000000000041027.
- 5.
- 6.Open revascularization for chronic mesenteric ischemia in the endovascular era: a quaternary-center experience and management algorithm. Jornal vascular brasileiro. 2024.PubMed-indexed articleRegistry / cohort2024
Open revascularization for chronic mesenteric ischemia in the endovascular era: a quaternary-center experience and management algorithm. Jornal vascular brasileiro. 2024. doi:10.1590/1677-5449.202301482.
- 7.Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting. Asian journal of endoscopic surgery. 2026.PubMed-indexed articleClinical practice guideline2026
Consensus Statement on Precision Anatomy and Treatment Strategies for Median Arcuate Ligament Syndrome: AOB Consensus Meeting. Asian journal of endoscopic surgery. 2026. doi:10.1111/ases.70208.
- 8.Median Arcuate Ligament Syndrome is Effectively Relieved with Minimally Invasive Surgery. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2022.PubMed-indexed article2022
Median Arcuate Ligament Syndrome is Effectively Relieved with Minimally Invasive Surgery. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2022. doi:10.4293/jsls.2022.00067.
- 9.Robotic Surgery for Median Arcuate Ligament Syndrome. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2020.PubMed-indexed article2020
Robotic Surgery for Median Arcuate Ligament Syndrome. JSLS: Journal of the Society of Laparoendoscopic Surgeons. 2020. doi:10.4293/jsls.2020.00014.
- 10.Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome. Asian journal of endoscopic surgery. 2026.PubMed-indexed articleClinical practice guideline2026
Consensus Statement on the Timing of Median Arcuate Ligament Release in Patients With Pancreaticoduodenal or Gastroduodenal Artery Aneurysms Associated With Median Arcuate Ligament Syndrome. Asian journal of endoscopic surgery. 2026. doi:10.1111/ases.70200.
- 11.Diagnosis and Management of Isolated Superior Mesenteric Artery Dissection: A Systematic Review and Meta-Analysis. Korean circulation journal. 2019.PubMed-indexed articleMeta-analysis / systematic review2019
Diagnosis and Management of Isolated Superior Mesenteric Artery Dissection: A Systematic Review and Meta-Analysis. Korean circulation journal. 2019. doi:10.4070/kcj.2018.0429.
- 12.Presentation, treatment, and outcomes in patients with spontaneous isolated celiac artery dissection. Scientific reports. 2025.PubMed-indexed articleRegistry / cohort2025
Presentation, treatment, and outcomes in patients with spontaneous isolated celiac artery dissection. Scientific reports. 2025. doi:10.1038/s41598-024-72587-6.
- 13.Long-Term Outcomes of Spontaneous Isolated Superior Mesenteric Artery Dissection. Annals of vascular diseases. 2019.PubMed-indexed articleRegistry / cohort2019
Long-Term Outcomes of Spontaneous Isolated Superior Mesenteric Artery Dissection. Annals of vascular diseases. 2019. doi:10.3400/avd.oa.19-00082.
- 14.Comparison of Superior Mesenteric Artery Remodeling and Clinical Outcomes between Conservative or Endovascular Treatment in Spontaneous Isolated Superior Mesenteric Artery Dissection. Journal of clinical medicine. 2022.PubMed-indexed articleRegistry / cohort2022
Comparison of Superior Mesenteric Artery Remodeling and Clinical Outcomes between Conservative or Endovascular Treatment in Spontaneous Isolated Superior Mesenteric Artery Dissection. Journal of clinical medicine. 2022. doi:10.3390/jcm11020465.
- 15.Early and Midterm Outcomes of Open and Endovascular Revascularization of Chronic Mesenteric Ischemia. World journal of surgery. 2020.PubMed-indexed articleRegistry / cohort2020
Early and Midterm Outcomes of Open and Endovascular Revascularization of Chronic Mesenteric Ischemia. World journal of surgery. 2020. doi:10.1007/s00268-020-05513-2.
- 16.Cost-Effectiveness Analysis of Open Versus Endovascular Revascularization for Chronic Mesenteric Ischemia. Annals of vascular surgery. 2023.PubMed-indexed article2023
Cost-Effectiveness Analysis of Open Versus Endovascular Revascularization for Chronic Mesenteric Ischemia. Annals of vascular surgery. 2023. doi:10.1016/j.avsg.2023.02.013.
- 17.Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization. Journal of vascular surgery cases and innovative techniques. 2023.PubMed-indexed articleCase report2023
Chronic mesenteric ischemia-induced intestinal dysbiosis resolved after revascularization. Journal of vascular surgery cases and innovative techniques. 2023. doi:10.1016/j.jvscit.2022.101084.
Educational use only
AI assists this editorial workflow. Published updates are human-reviewed before publication.
Not intended to diagnose, monitor, predict, prognose, treat, or alleviate disease.
Verify clinically relevant information against primary sources and current guidelines.